Lilly’s Zepbound has become the first prescription medicine approved to treat adults with moderate to severe obstructive sleep apnoea (OSA) and obesity.

Mark Gurman, in his Power On newsletter, says that Apple is working on heart rate measuring technology, and it could be ready ...

Elizabeth Devaney was 37 years old, and very fit, when she went for a procedure known as guided foam ablation, in October ...

Zepbound, from drugmaker Eli Lilly, is already approved for people who are obese or overweight and have a related health condition, such as type 2 diabetes, high cholesterol or high blood ...

Did you spend the year counting your macros and considering whether the carnivore diet would solve all your problems? Let's ...

Eli Lilly's Zepbound has become the first drug to be FDA-approved for obstructive sleep apnoea (OSA), a sleep-related ...

Novo Nordisk and Eli Lilly are currently a duopoly in the obesity market, which reached a value of $24 billion last year ...